Clinical Trials Directory

Trials / Completed

CompletedNCT04119765

Plasma Oxalate in Patient With Short Bowel

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hyperoxaluria due to fat malabsorption is seen in patients suffering from short bowel and can lead to stones and nephrocalcinosis. Not all patients are prone to these renal complications. only urinary oxaluria is measured in practice. Plasma oxalate shouldn't increase theoretically in these patients. However recent report showed an increase of plasma oxalate in patient with enteric hyperoxaluria. The aim of this study is to assess the plasma oxalate distribution in this specific population to have a new tool to predict renal complication of these patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood samplingblood sampling will be used to perform oxalemia and FGF23 quantitative analysis
BIOLOGICALUrine samplingurine sampling will be used to measure glycolate urinary rate (glycolaturia) and to perform urinary inflammation markers quantitative analysis
PROCEDUREPulse Wave Velocity (PWV) measurementPWV will be measured thank to the Complior® device
PROCEDUREcentral pressure measurementcentral pressure will be measured thank to the Complior® device

Timeline

Start date
2020-02-27
Primary completion
2022-05-04
Completion
2022-05-04
First posted
2019-10-08
Last updated
2022-07-21

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04119765. Inclusion in this directory is not an endorsement.